Anastrozole
- Product NDC
- 62135-490
- 11-digit product format
- 621350490
- Labeler code
- 62135
- Product ID
- 62135-490_458bf011-d6c4-f0c4-e063-6394a90a638b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Anastrozole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA206037
- Marketing category
- ANDA
- Marketing start
- 2019-02-28
- Substance
- ANASTROZOLE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anastrozole
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ANASTROZOLE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2Z07MYW1AZ |
| Rxcui | 199224 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-490-30 | Anastrozole | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
| 62135-490-90 | Anastrozole | 90 in 1 BOTTLE | TABLET | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-490 | ANASTROZOLE TABLET [CHARTWELL RX, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20241012_da6ae05c-81e9-492a-a4c9-be3f1f367b59.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62135-490-30 | 62135049030 | 30 TABLET in 1 BOTTLE (62135-490-30) | 30 tablet | 2022-01-17 | 0000-00-00 | No | No | Current |
| 62135-490-90 | 62135049090 | 90 TABLET in 1 BOTTLE (62135-490-90) | 90 tablet | 2022-01-17 | 0000-00-00 | No | No | Current |